G2086 Off base opioid tx 70minOffice-based treatment for opioid use disorder, including development of the treatment plan, care coordination, individual therapy and group therapy and counseling; at least 70 minutes in the first calendar month
Status A: active, paid separately under the PFS if covered. National amounts: non-facility $491.33, facility $362.73 (total RVUs 14.71 / 10.86 × $33.4009 conversion factor). Work RVU 8.36, practice expense RVU 5.73 non-facility and 1.88 facility, malpractice RVU 0.62. Global period XXX. Qualifying APM participants are paid at a $33.5675 conversion factor.
G2086 appears in 1 coverage policy from Aetna.
| Payer | Policy | Role in policy | Reviewed | Document |
|---|---|---|---|---|
| Aetna | Extended-Release Buprenorphine Injectables (0910) | listed, no stance | Dec 30, 2025 | payer document |
Prior authorization required or conditional in IN.
From payers' published prior-auth lists, coverage policies and state Medicaid fee schedules, updated Oct 16, 2026. The role is what the policy's own code table or text says about the code. Not a guarantee of coverage or payment; verify with the payer. CPT® is a registered trademark of the American Medical Association.